{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T01:17:43Z","timestamp":1787361463742,"version":"build-2736575974"},"reference-count":40,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Obesity Science &amp;amp; Practice"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>GLP\u20101 RAs are effective in treating obesity; however, they typically result in significant loss of skeletal muscle mass. Real\u2010world evidence to inform systematic guidelines and clinical implementation for preserving skeletal muscle mass and reducing cardiometabolic risk with lifestyle modifications on GLP\u20101 RAs remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study evaluated the effectiveness of the TouchCare Method, a lifestyle intervention incorporating nutrition and exercise with GLP\u20101 RAs, for improving body composition and cardiometabolic risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective chart review included patients enrolled in Bucks Health and Wellness between February 2024 and September 2025, for at least 12 month (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0187). The TouchCare Method incorporates registered dietitian counseling, progressive exercise programming, mobile self monitoring, and body composition analysis during visits. Primary outcomes included: clinically significant weight loss (&gt;\u00a010% of body weight), proportion of weight loss from skeletal muscle mass, and changes in total\u2010C, LDL\u2010C, Apolipoprotein B, Triglycerides, HbA1c, and blood pressure at 12\u00a0months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients adherent to the TouchCare Method for 12\u00a0months were included in the final analysis (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0171). Clinically significant weight loss (\u2265\u00a010%) was achieved by 69.56% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0139) of patients. Skeletal muscle mass accounted for 12.22%\u00a0\u00b1\u00a08.73% of total weight loss. Among prediabetic patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a095), 74.7% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a071) reached euglycemia by 12 months. Patients with Stage II hypertension or higher (77% of the cohort) demonstrated improved blood pressure control, with most reaching\u00a0&lt;\u00a0140\/90\u00a0mmHg. Patients with HLD experienced significant reductions in Total\u2010C (24.71\u00a0\u00b1\u00a023.31\u00a0mg\/dL), LDL\u2010C (\u221213.75\u00a0\u00b1\u00a021.51\u00a0mg\/dL), and ApoB (\u221214.24\u00a0\u00b1\u00a016.19\u00a0mg\/dL). All lipid and HgA1c changes were statistically significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The TouchCare Method may improve GLP\u20101 RA treatment outcomes by providing comprehensive structured lifestyle interventions supporting clinically significant weight loss while preserving skeletal muscle mass and improving cardiometabolic risk factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/osp4.70140","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T07:36:30Z","timestamp":1775288190000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing Obesity Management With GLP\u20101 Agonist Medication Through Mobile Health Technology, Nutrition Therapy, and Progressive Strength Training: A Retrospective Program Review"],"prefix":"10.1002","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6148-3103","authenticated-orcid":false,"given":"Elizabeth Sharp","family":"Edens","sequence":"first","affiliation":[{"name":"TouchCare Method, Health Meets Wellness, Bucks Health and Wellness  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Falise","sequence":"additional","affiliation":[{"name":"TouchCare Method, Health Meets Wellness, Bucks Health and Wellness  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Smith","sequence":"additional","affiliation":[{"name":"TouchCare Method, Health Meets Wellness, Bucks Health and Wellness  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elle","family":"Bernardo","sequence":"additional","affiliation":[{"name":"TouchCare Method, Health Meets Wellness, Bucks Health and Wellness  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206038"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.10333"},{"key":"e_1_2_11_4_1","first-page":"1","volume-title":"The Obesity Epidemic: Growing Health Impacts and Cost Implications","year":"2025"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889\u2010024\u201021061\u2010z"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15728"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2026.168172"},{"key":"e_1_2_11_8_1","unstructured":"Lean Body Mass\u2014An Overview | Sciencedirect Topics. Accessed January 21 2026 https:\/\/www.sciencedirect.com\/topics\/agricultural\u2010and\u2010biological\u2010sciences\/lean\u2010body\u2010mass."},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156113"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13916"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16275"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.06.010"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23703"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.24336"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.112.044321"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2024.06.030"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsem\u20102024\u2010002363"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072473"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028198"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032183"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20946"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.orcp.2016.01.004"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20396"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.2196\/11819"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2010.10.008"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2012.1044"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.obpill.2024.100133"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare14010060"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdnut.2024.104486"},{"key":"e_1_2_11_30_1","unstructured":"England NHS \u201cNHS England \u00bb Interim Commissioning Guidance: Implementation of the NICE Technology Appraisal TA1026 and the NICE Funding Variation for Tirzepatide (Mounjaro) for the Management of Obesity \u201d Published March 27 2025 Accessed January 22 2026 https:\/\/www.england.nhs.uk\/publication\/interim\u2010commissioning\u2010guidance\u2010implementation\u2010of\u2010the\u2010nice\u2010technology\u2010appraisal\u2010ta1026\u2010and\u2010the\u2010nice\u2010funding\u2010variation\u2010for\u2010tirzepatide\u2010mounjaro\u2010for\u2010the\u2010management\u2010of\u2010obesity\/."},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70096"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.2196\/72577"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.70127"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2023.05.003"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23640"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/482564"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.2165\/00007256\u2010200636030\u201000005"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.2337\/db23\u20101704\u2010P"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/obesities5020026"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.8.766"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2021.20410"}],"container-title":["Obesity Science &amp; Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/osp4.70140","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/osp4.70140","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/osp4.70140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:00:39Z","timestamp":1777291239000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/osp4.70140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1002\/osp4.70140"],"URL":"https:\/\/doi.org\/10.1002\/osp4.70140","archive":["Portico"],"relation":{},"ISSN":["2055-2238","2055-2238"],"issn-type":[{"value":"2055-2238","type":"print"},{"value":"2055-2238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-12-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70140"}}